Found: 22
Select item for more details and to access through your institution.
The drug interaction potential of daprodustat when coadministered with pioglitazone, rosuvastatin, or trimethoprim in healthy subjects.
- Published in:
- Pharmacology Research & Perspectives, 2018, v. 6, n. 2, p. 1, doi. 10.1002/prp2.327
- By:
- Publication type:
- Article
Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pharmacokinetics of Daprodustat and Metabolites in Individuals with Normal and Impaired Hepatic Function.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 5, p. 562, doi. 10.1002/cpdd.1090
- By:
- Publication type:
- Article
Clinical Pharmacokinetics of Daprodustat: Results of an Absorption, Distribution, and Excretion Study With Intravenous Microtracer and Concomitant Oral Doses for Bioavailability Determination.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1419, doi. 10.1002/cpdd.1029
- By:
- Publication type:
- Article
A Randomized, Placebo‐ and Positive‐Controlled, Single‐Dose, Crossover Thorough QT/QTc Study Assessing the Effect of Daprodustat on Cardiac Repolarization in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 627, doi. 10.1002/cpdd.342
- By:
- Publication type:
- Article
Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents—post hoc analyses of the ASCEND-ND and ASCEND-D trials.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 8, p. 1890, doi. 10.1093/ndt/gfac342
- By:
- Publication type:
- Article
ASCEND-ND trial: study design and participant characteristics.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 11, p. 2157, doi. 10.1093/ndt/gfab318
- By:
- Publication type:
- Article
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 5, p. 960, doi. 10.1093/ndt/gfab065
- By:
- Publication type:
- Article
Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Anemia and mortality in patients with nondialysis-dependent chronic kidney disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Improving Metabolic Control Leads to Better Working Memory in Adults With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2006, v. 29, n. 2, p. 345, doi. 10.2337/diacare.29.02.06.dc05-1626
- By:
- Publication type:
- Article
Effect of renal function and dialysis modality on daprodustat and predominant metabolite exposure.
- Published in:
- Clinical Kidney Journal, 2019, v. 12, n. 5, p. 693, doi. 10.1093/ckj/sfz013
- By:
- Publication type:
- Article
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis.
- Published in:
- Clinical Kidney Journal, 2019, v. 12, n. 1, p. 139, doi. 10.1093/ckj/sfy014
- By:
- Publication type:
- Article
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease.
- Published in:
- Clinical Kidney Journal, 2019, v. 12, n. 1, p. 129, doi. 10.1093/ckj/sfy013
- By:
- Publication type:
- Article
Normalization of skeletal muscle glycogen synthesis and glycolysis in rosiglitazone-treated Zucker fatty rats: an in vivo nuclear magnetic resonance study.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Commentary on 'case series of liver failure associated with rosiglitazone and pioglitazone' by Floyd et al.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2009, v. 18, n. 12, p. 1244, doi. 10.1002/pds.1840
- By:
- Publication type:
- Article
Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D).
- Published in:
- American Journal of Nephrology, 2023, v. 54, n. 1/2, p. 1, doi. 10.1159/000528696
- By:
- Publication type:
- Article
Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial.
- Published in:
- American Journal of Nephrology, 2021, v. 52, n. 1, p. 26, doi. 10.1159/000513103
- By:
- Publication type:
- Article
A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes.
- Published in:
- Diabetes Care, 2009, v. 32, n. 5, p. e58, doi. 10.2337/dc09-0125
- By:
- Publication type:
- Article
Characterization of chronic and acute ESA hyporesponse: a retrospective cohort study of hemodialysis patients.
- Published in:
- BMC Nephrology, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12882-015-0138-x
- By:
- Publication type:
- Article
Characterization of chronic and acute ESA hyporesponse: a retrospective cohort study of hemodialysis patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article